Sponsor Pipeline

Arctic Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-03 NCT07741526 Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With… Phase 2 Active, Not Recruiting
2026-07-21 NCT07716865 Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C… Phase 2 Active, Not Recruiting
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07716865 Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C… Hereditary Cystatin C Amyloid Angiopathy (HCCAA) Active, Not Recruiting
NCT07741526 Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With… Alzheimer´s Disease Active, Not Recruiting
Disease Areas
Alzheimer's Disease (1)
Get alerts when Arctic Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free